MUMBAI, India, June 8, 2023 /PRNewswire/ -- The Piramal Critical Care (PCC) business of Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a producer of inhaled anesthetics and a global player in hospital generics, has announced today the appointment of Jeffrey Hampton as President and Chief Operating Officer. In his new position, Hampton will be stationed in the United States.

With a degree in Marketing from the University of Florida, Hampton joins PCC from Accord Healthcare, where he served as President and was responsible for accelerating the company's growth strategy. Previously, he was Apotex's Senior Vice President and General Manager for the US and Latin America regions. At Apotex, Hampton restructured the US commercial team to maximize efficiency and established procedures to identify and execute lifecycle management practices to improve profitability and market penetration. His career, thus far, spans more than three decades in sales and marketing, regulation, business operations, sales strategy, distribution and business development.

Hampton has also worked with several leading pharmaceutical companies including Osmotica Pharmaceuticals, Dabur Pharma and IVAX Pharmaceuticals.

Peter DeYoung, CEO, Global Pharma, Piramal Pharma Limited, said, "I welcome Jeff to Piramal Critical Care and wish him every success in his new role. His experience in sales and marketing will help us develop strategies for Stronger, long-term global operations for profitable growth His experience across functions bodes well for the business as we aim to further strengthen PCC's position as a global leader in complex hospital generics Jeff has also He has been associated with leading pharmaceutical companies and is well-versed in building a patient- and customer-centric culture, which aligns with our core values."

Speaking on the occasion of his joining PCC, Hampton said, "It is a true honor to join such a fast-paced, growth-oriented global company like Piramal Critical Care. I look forward to leading PCC's growth strategies to expand our presence."

About Piramal Critical Care:

Piramal Critical Care (PCC) is a global player in anesthesia, pain management and intrathecal therapy. PCC maintains an extensive presence in more than 100 countries, including the US and European markets. Our product portfolio includes inhalation anesthetics, injectable pain and anesthesia drugs, intrathecal therapy and other injectables. Piramal Critical Care has manufacturing and process development capabilities with manufacturing facilities in Bethlehem, PA, USA and Digwal, Telangana, India, inspected by the US FDA, UK MHRA and other regulatory bodies, and collaborates with leading organizations in developing and manufacturing pharmaceuticals around the world.

For more information, visit: www.piramalcriticalcare.com

About Piramal Pharma Ltd:

Piramal Pharma Limited (PPL, NSE: PPLPHARMA) (BSE: 543635), offers a portfolio of differentiated products and services through its 17 global facilities including manufacturing and development capabilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a business of Complex Hospital Generics; and the India Consumer Healthcare business, which sells over-the-counter products. In addition, one of PPL's ​​partner companies, Allergan India Private Limited, is a joint venture with AbbVie Inc. and has become one of the market leaders in the area of ​​ophthalmic therapy. In addition, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a 20% strategic growth investment from the Carlyle Group.

For more information, visit: https://www.piramal.com/pharma/, Facebook, Twitter, LinkedIn

Responsibility:

Piramal Pharma Limited proposes, subject to applicable law, receipt of necessary approvals, market conditions and other considerations, a rights issue of its shares in the near future and has submitted a draft offer letter to the Securities and Exchange Board of India.

Photo: https://mma.prnewswire.com/media/2094143...Photo: https://mma.prnewswire.com/media/2094144...Logo: https://mma.prnewswire.com/media/ 2094149...

View original content: https://www.prnewswire.com/es/comunicados-de-prensa/piramal-critical-care-nombra-a-jeffrey-hampton-presidente-y-director-de-operaciones-301845752.html